Your browser doesn't support javascript.
loading
Acquisition of IDH2 mutations in relapsed/refractory AML is associated with worse patient outcomes.
Song, Amy; Altabbakh, Omar; Sallman, David A; Padron, Eric; Talati, Chetasi; Hussaini, Mohammad O.
Afiliação
  • Song A; New Jersey Medical School, Rutgers University, Newark, NJ, USA.
  • Altabbakh O; Nova Southeastern University, Clearwater, FL, USA.
  • Sallman DA; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Padron E; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Talati C; Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Hussaini MO; Department of Pathology, Moffitt Cancer Center, FL Tampa, FL, USA.
Eur J Haematol ; 107(6): 609-616, 2021 Dec.
Article em En | MEDLINE | ID: mdl-34407254
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Isocitrato Desidrogenase / Mutação Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Isocitrato Desidrogenase / Mutação Idioma: En Ano de publicação: 2021 Tipo de documento: Article